Masafumi Oyama
Saitama Medical University, Saitama International Medical Center
Papers
4
Total Citations
19
H-Index
2
About
Dr. Masafumi Oyama is a pioneering urologic surgeon whose work centers on advancing minimally invasive robotic surgery, particularly for renal cell carcinoma and upper tract urothelial carcinoma. His major contributions lie in evaluating and refining the Senhance® robotic system, an innovative platform that offers haptic feedback, eye-tracking camera control, and reusable 3 mm instruments—features that reduce costs and improve surgical precision. Dr. Oyama’s most cited paper, “Initial experience of laparoscopic radical nephrectomy using the Senhance® robotic system for renal cell carcinoma” (2021, 13 citations), established the feasibility of this approach. He further expanded the technique by introducing the “double bipolar method” (DBM) for robot-assisted partial cystectomy, a novel adaptation from general surgery and gynecology into urology. His work on 3 mm bipolar instruments in laparoscopic renal surgery demonstrates a commitment to minimizing trauma and enhancing recovery. With a growing portfolio of publications from 2021 to 2024, Dr. Oyama is shaping the future of cost-effective, precise robotic urologic surgery, making him a key figure for students and researchers interested in surgical innovation and translational robotics.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Robot-Assisted Partial Cystectomy Using the “Double Bipolar Method”2 citations · 2024
- 4